Options
Candidalysin is a fungal peptide toxin critical for mucosal infection
ISSN
1476-4687
0028-0836
Date Issued
2016
Author(s)
Moyes, David L.
Wilson, Duncan
Richardson, Jonathan P.
Mogavero, Selene
Tang, Shirley X.
Wernecke, Julia
Hoefs, Sarah
Gratacap, Remi L.
Robbins, Jon
Runglall, Manohursingh
Murciano, Celia
Blagojevic, Mariana
Thavaraj, Selvam
Foerster, Toni M.
Hebecker, Betty
Kasper, Lydia
Vizcay, Gema
Iancu, Simona I.
Kichik, Nessim
Haeder, Antje
Kurzai, Oliver
Luo, Ting
Krueger, Thomas
Kniemeyer, Olaf
Cota, Ernesto
Wheeler, Robert T.
Gutsmann, Thomas
Hube, Bernhard
Naglik, Julian R.
DOI
10.1038/nature17625
Abstract
Cytolytic proteins and peptide toxins are classical virulence factors of several bacterial pathogens which disrupt epithelial barrier function, damage cells and activate or modulate host immune responses. Such toxins have not been identified previously in human pathogenic fungi. Here we identify the first, to our knowledge, fungal cytolytic peptide toxin in the opportunistic pathogen Candida albicans. This secreted toxin directly damages epithelial membranes, triggers a danger response signalling pathway and activates epithelial immunity. Membrane permeabilization is enhanced by a positive charge at the carboxy terminus of the peptide, which triggers an inward current concomitant with calcium influx. C. albicans strains lacking this toxin do not activate or damage epithelial cells and are avirulent in animal models of mucosal infection. We propose the name 'Candidalysin' for this cytolytic peptide toxin; a newly identified, critical molecular determinant of epithelial damage and host recognition of the clinically important fungus, C. albicans.